NASDAQ: MTEXMannatech Inc Stock
$16.05-0.23 (-1.41%)
Updated Jan 27, 2023
MTEX Price
$16.05
Fair Value Price
$24.03
Market Cap
$29.83M
52 Week Low
$15.49
52 Week High
$38.30
P/E
6.77x
P/B
1.6x
P/S
0.28x
PEG
0.18x
Dividend Yield
4.98%
Revenue
$142.37M
Earnings
$4.61M
Gross Margin
78%
Operating Margin
2.41%
Profit Margin
3.2%
Debt to Equity
1.82
Operating Cash Flow
$387k
Beta
0.44
Next Earnings
Mar 13, 2023
Ex-Dividend
N/A
Next Dividend
N/A
MTEX Overview
Mannatech, Incorporated operates as a health and wellness company worldwide. It develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management products. The company primarily sells its products directly, as well as through e-commerce and network marketing channels. Mannatech, Incorporated was founded in 1993 and is headquartered in Flower Mound, Texas.
Zen Score
–
Industry Average (36)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how MTEX scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
MTEX ($16.05) is undervalued by 33.2% relative to our estimate of its Fair Value price of $24.03 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
MTEX ($16.05) is significantly undervalued by 33.2% relative to our estimate of its Fair Value price of $24.03 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
MTEX ($16.05) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more MTEX due diligence checks available for Premium users.
Be the first to know about important MTEX news, forecast changes, insider trades & much more!
MTEX News
Valuation
MTEX fair value
Fair Value of MTEX stock based on Discounted Cash Flow (DCF)
Price
$16.05
Fair Value
$24.03
Undervalued by
33.20%
MTEX ($16.05) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
MTEX ($16.05) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
MTEX ($16.05) is trading below... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
MTEX price to earnings (PE)
For valuing profitable companies with steady earnings
Company
6.77x
Industry
25.33x
Market
23.59x
MTEX is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
MTEX is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
MTEX price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
1.6x
Industry
6.35x
MTEX is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
MTEX price to earnings growth (PEG)
For valuing profitable companies with growth potential
MTEX is good value based... subscribe to Premium to read more.
PEG Value Valuation
MTEX's financial health
Profit margin
Revenue
$35.5M
Net Income
$1.2M
Profit Margin
3.4%
MTEX's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials
MTEX's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$52.5M
Liabilities
$33.9M
Debt to equity
1.82
MTEX's short-term assets ($36.44M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
MTEX's short-term assets ($36.44M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
MTEX's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
MTEX's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$1.0M
Investing
-$353.0k
Financing
-$1.5M
MTEX's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
MTEX vs Household & Personal Product Stocks
Mannatech Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.